| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/17/2005 | US20050039225 Hyperactive light signal related molecule of HFR1-deltaN105 and transgenic plant thereof |
| 02/17/2005 | US20050039224 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 02/17/2005 | US20050039223 Knock-in-mouse |
| 02/17/2005 | US20050039222 Sgrf gene-modified non-human animals |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050038610 Apparatus and method for automated protein design |
| 02/17/2005 | US20050038255 Stereoselective preparation of cyclic l-amino acids |
| 02/17/2005 | US20050038239 Locked nucleic acid conjugate for use in treatment of cell proliferative disorders |
| 02/17/2005 | US20050038238 Using triplex formation as a tool in prevention of viral gene expression; viricides |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050038232 Monoclonal antibody for use in detection and screening for biological warfare agents |
| 02/17/2005 | US20050038229 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050038086 Epothilone derivatives and methods for making and using the same |
| 02/17/2005 | US20050037989 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 02/17/2005 | US20050037988 Determination competitive binder between Rna and target compound in plants |
| 02/17/2005 | US20050037987 Methods of identifying kinases and uses thereof |
| 02/17/2005 | US20050037986 p53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037968 Peptide leukotriene receptor |
| 02/17/2005 | US20050037962 Modulating angiogenesis by modulating gene expression or activation of syndecan-2; antitumor agents |
| 02/17/2005 | US20050037956 Screening method for agents useful in treating diabetes |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037497 Compounds and methods to enhance rAAV transduction |
| 02/17/2005 | US20050037496 Polyampholytes for delivering polyions to a cell |
| 02/17/2005 | US20050037495 Human CNS cell lines and methods of use therefor |
| 02/17/2005 | US20050037494 Using antisense agents to reduce and/or prevention genic expression associated with cardi-vascular complications; gene therapy |
| 02/17/2005 | US20050037492 Nutrient broth for propagation of progenitor cells for use in drug screeniing and human therapy |
| 02/17/2005 | US20050037487 Recombinant influenza vectors with a PolII promoter and ribozymes for vaccines and gene therapy |
| 02/17/2005 | US20050037478 Crystal structure of glutamate racemase (MurI) |
| 02/17/2005 | US20050037473 transformed E. coli comprises a polyhydroxyalkanoate (PHA) synthase gene of Pseudomonas species; producing PHA using a microorganism transformed with a recombinant vector containing the maoC gene and a recombinant vector containing a PHA synthase gene |
| 02/17/2005 | US20050037468 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulator for use in treatment and prevention of pain; antinociceptive agents |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037462 Expression vector comprising nucleotide sequences coding g protein for use in generating immunoglobulins for use in prevention, treatment and diagnosis of cell proliferative disorders |
| 02/17/2005 | US20050037460 Potassium channels and genes encoding these potassium channels |
| 02/17/2005 | US20050037459 Variant humicola grisea CBH1.1 |
| 02/17/2005 | US20050037455 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders |
| 02/17/2005 | US20050037453 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 02/17/2005 | US20050037445 analyzing molecules expressed on the cell surface of cancer cells and comparing to nonmalignant cells; screening for cancer specific promoters to be used singly or in combination for delivery and expression of therapeutic genes for treatment of cancer |
| 02/17/2005 | US20050037444 Method for identification isolation and production of antigens to a specific pathogen |
| 02/17/2005 | US20050037439 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 02/17/2005 | US20050037435 Generating new compounds without predetermining a desired structure or composition; rational drug design |
| 02/17/2005 | US20050037427 Structure for presenting desired peptide sequences |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037415 Using transgenic cells as tools in identifying therapeutic amino acids; mimetic peptides; drug screening |
| 02/17/2005 | US20050037414 Nucleotide sequences specific to hepatitis B viral genome for use as amplification tool in detection of viral infection |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037410 Detection format for hot start real time polymerase chain reaction |
| 02/17/2005 | US20050037409 Identifying and quantifying fusion protein comprising translocating markers that are responsive to altered cellular conditions; detecting vector transformed cell |
| 02/17/2005 | US20050037396 compounds for analyzing primer extension products incorporating universal bases; microsatellite analysis |
| 02/17/2005 | US20050037392 Optical sorting method |
| 02/17/2005 | US20050037391 Polypeptide |
| 02/17/2005 | US20050037390 Exposing transgenic cell comprising vectors which contain erythropoietin regulator sequences and reporter molecules to erythropoietin modulating protein, monitoring gene expression; identifying agents for treatment of blood disorders |
| 02/17/2005 | US20050037387 Modulation of the RNA interference pathway |
| 02/17/2005 | US20050037385 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037375 Using ligand-receptor interactions as tool to monitor effectiveness of modulators in disease treatment which act via receptor binding; drug screening and design |
| 02/17/2005 | US20050037367 Apparatus comprising microarray of nucleic acid probes fabricated at known locations for use in imaging nucleic acid hybridization |
| 02/17/2005 | US20050037364 Techniques for recording signals |
| 02/17/2005 | US20050037362 Using microarray hybridization to quantify and analyze RNA interference; detection, identification and/or quantification of multiple gene-specific short interfering RNA sequences |
| 02/17/2005 | US20050037361 Kit comprising betaine and sorbitol additives for use in decreasing stalling during replication of mononucleotide, dinucleotide, tetranucleotide and pentanucleotide microsatellite sequences; genotyping |
| 02/17/2005 | US20050037359 Differentiating and identifying polynucleotides and/or polypeptides via binding to large scale integrated circuit (LSI); non-radioacitve labeling of biopolymers |
| 02/17/2005 | US20050037358 Converting immunoglobulin variable domain messenger RNA into CDNA using univversal primer, amplifying, inserting and replicating nucleotide sequences in vector and host cells; immunotherapy |
| 02/17/2005 | US20050037357 Matrix comprising immobilized polynucleotide probes for use in determining translation efficiency of messenger RNA variants and monitor accuracy gene expression in cells |
| 02/17/2005 | US20050037355 Measuring intracellular adenosine triphosphate and/or gene expression in transgenic cell via monitoring luciferin bioluminescent signals; genetiic engineering and reporter molecules |
| 02/17/2005 | US20050037351 Method of purifiying nucleic acid using nonwoven fabric and detection method |
| 02/17/2005 | US20050037347 Novel cancer-associated genes |
| 02/17/2005 | US20050037346 Distinguish minority template in the presence of an excess of normal template with a thermostable ligase; useful for the detection of cancer-associated mutations; quantitative measure of the amount or ratio of minority template; a thermostable mutant ligase |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037340 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 02/17/2005 | US20050037339 Methods of selecting internalizing antibodies |
| 02/17/2005 | US20050037337 Papilloma virus sequences |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037335 Method for identifying novel transcriptional regulatory proteins |
| 02/17/2005 | US20050037085 Microencapsulated DNA for vaccination and gene therapy |
| 02/17/2005 | US20050037075 Targeted delivery of controlled release polymer systems |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050037021 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions |
| 02/17/2005 | US20050037017 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/17/2005 | US20050037010 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037003 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 02/17/2005 | US20050036997 Molecular modeling of the binding sites for anisomycin, azithromycin, erythromycin, linezolid, tylosin, carbomycin A, spiramycin, virginiamycin, sparsomycin and blasticidin using the Haloarcular marismortui large ribosomal subunit; drug design and drug screening |
| 02/17/2005 | US20050036995 Immunogens; tumor antigens; kits |
| 02/17/2005 | US20050036994 Compounds and methods for downregulating the effects of TGF-beta |
| 02/17/2005 | US20050036992 Novel use of liver X receptor agonists |
| 02/17/2005 | US20050036989 Subgroup B adenoviral vectors for treating disease |
| 02/17/2005 | US20050036988 Administering vector which transduces hepatic stellate cells which suppresses collagen and/or tumor growth factor-beta expression; kits |
| 02/17/2005 | US20050036987 Suicide gene-containing strains of bacteria, fungi, and protists; tumor specific shigella species |
| 02/17/2005 | US20050036986 Antisense agents; gene expression inhibition; prostate cancer; hyperplasia; carcinoma |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | US20050034989 Mixture of gel mincing tube and mesh; dividing; centrifuging; drawing through porous material |
| 02/17/2005 | US20050034809 Integrated tool with interchangeable wet processing components for processing microfeature workpieces and automated calibration systems |
| 02/17/2005 | DE10333509A1 New recognition molecules for the vascular endothelial growth factor gene, useful for treatment, diagnosis and monitoring of solid tumors and leukemia |
| 02/17/2005 | DE10331291A1 Varianten der 3-Phosphoglyceratdehydrogenase mit reduzierter Hemmung durch L-Serin und dafür codierende Gene Variants of the 3-phosphoglycerate dehydrogenase with reduced inhibition by L-serine, and genes coding therefor |
| 02/17/2005 | DE10149684B4 Vorrichtung zur Halterung eines Substanzbibliothekenträgers A device for holding a substance library support |
| 02/17/2005 | CA2678736A1 Novel multifunctional il-2 - il-18 fusion proteins |
| 02/17/2005 | CA2574227A1 Utilisation of constructs comprising recombination sequence motifs for enhancing gene expression in moss |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2537555A1 Compositions and methods for the therapy and diagnosis of lung cancer |